Kelzy (Dienogest, Ethinylestradiol | Lactose)

Dienogest acts as a progestogen, binding to progesterone receptors and inhibiting the LH and FSH surge that triggers ovulation. Ethinylestradiol, an estrogen, reinforces negative feedback on the hypothalamic‑pituitary axis, stabilizes the endometrium, and thickens cervical mucus, together preventing fertilization and implantation.

The specific dosing regimen for Kelzy is determined by the prescribing healthcare professional. Typically, the product is taken once daily at the same time each day, but the exact number of tablets per pack and any missed‑dose instructions are set by the prescriber based on individual patient needs.

Kelzy is contraindicated during pregnancy because it is designed to prevent conception. If pregnancy occurs, the product should be discontinued. Regarding breastfeeding, clinicians should weigh the benefits against potential risks, as hormonal exposure may affect milk production and infant hormone balance; a healthcare provider should be consulted.

To order Kelzy, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details, and any necessary import documentation.

Kelzy contains dienogest, a progestogen with a favorable metabolic profile, combined with ethinylestradiol. Compared with older formulations that use levonorgestrel, dienogest may offer lower androgenic activity and a reduced impact on lipid metabolism, while maintaining comparable contraceptive efficacy and cycle control.

Kelzy tablets should be stored at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect them from excess moisture, direct sunlight, and heat. Keep the product out of reach of children and do not use tablets that appear discolored or damaged.

Kelzy is taken orally, usually as a single tablet each day, at the same time each day. The tablet is swallowed whole with water and can be taken with or without food. Consistency in timing helps maintain stable hormone levels and maximizes contraceptive effectiveness.

The most serious risks include thromboembolic events such as deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. These events are more likely in women with pre‑existing clotting disorders, smokers over 35, or those taking interacting medications that increase clotting risk.

Kelzy should not be used by women with a history of thromboembolic disease, uncontrolled hypertension, known or suspected estrogen‑dependent tumors, active liver disease, or those who are pregnant. It is also contraindicated in smokers over 35 years of age and in individuals taking medications that severely reduce its effectiveness.